Alba Rubio-San-Simón

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Teena Bhatla, Laura Hogan, David Trent Teachey, Francisco J Bautista Sirvent, John P Moppett, Pablo Velasco Puyó, Concetta Micalizzi, Claudia Rossig, Neerav Narendra Shukla, Gil Gilad, Franco Locatelli, Andre Baruchel, Michel Zwaan, Natalie S Bezler, Alba Rubio-San-Simón, David Taussig, Elizabeth A Raetz, Zhengwei J Mao, Brent Wood, Diana Alvarez Arias, Maria Krevvata, Ivo Nnane, Nibedita Bandyopadhyay, Lorena Lopez Solano, Robyn M Dennis, Robin Carson, Ajay Vora
Daratumumab in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: DELPHINUS Study. Blood (2024)
Francisco J Bautista Sirvent, Jaime Verdu, Didier Frappaz, Alba Rubio-San-Simón, Xavier Paoletti, Christian Michel Zwaan, Michela Casanova, Lynley V Marshall, Fernando Carceller, François Doz, Carole Lecinse, Gilles Vassal, Andrew D J Pearson, Pamela R Kearns, Lucas Moreno, null null
Evolution of the Innovative Therapies for Children With Cancer Consortium Trial Portfolio for Drug Development for Children With Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Francisco J Bautista Sirvent, Jaime Verdu, Didier Frappaz, Alba Rubio-San-Simón, Xavier Paoletti, Christian Michel Zwaan, Michela Casanova, Lynley V Marshall, Fernando Carceller, François Doz, Carole Lecinse, Gilles Vassal, Andrew D J Pearson, Pamela R Kearns, Lucas Moreno, null null
Evolution of the Innovative Therapies for Children With Cancer Consortium Trial Portfolio for Drug Development for Children With Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Rocio Vila, Alba Rubio-San-Simón, Pablo Zubiaur, Marcos Navares-Gómez, Patricia Gómez-Hernández, Begoña Arce, Luis Madero
Use of glucarpidase (carboxypeptidase-G2) in pediatric cancer patients: 11-year experience of a tertiary center. EJHaem 4 (4) (2023)
Alba Rubio-San-Simón, Natasha K A van Eijkelenburg, Raoull Hoogendijk, Henrik Hasle, Charlotte M Niemeyer, Michael N Dworzak, Marco Zecca, Marta Lopez-Yurda, Julie M Janssen, Alwin D R Huitema, Marry M van den Heuvel-Eibrink, Eric J Laille, Harm van Tinteren, Christian M Zwaan
Azacitidine (Vidaza ® ) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015). Paediatric drugs (2023)
Marta Cortes, Fernando Carceller, Alba Rubio-San-Simón, Sucheta J Vaidya, Francisco J Bautista Sirvent, Lucas Moreno
Access to early-phase clinical trials for children with relapsed and refractory neuroblastoma: A multicentre international study. Pediatric blood & cancer 69 (8) (2022)
Jaime Verdu, Francisco J Bautista Sirvent, Alba Rubio-San-Simón, Carlos Daniel Grasa Lozano, Luis Madero, Teresa de Rojas
Comment on: "Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences". Pediatric blood & cancer 67 (7) (2020)